While mutations in oncogenes such as PIK3CA and KRAS were detected in two samples (ENDO1 and ENDO3), mutations in tumor suppressor genes such as PTEN, ATM, and TP53 were not detected in any of the 15 ovarian endometriosis samples. This evidence concerns the gene KRAS and ovarian endometriosis.